Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.03
-0.42 (-2.72%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $967.25 million as of October 30, 2026. It is the 10,094th most valuable company in the world and the 2,257th biggest in the United States. Its market cap has increased by 112.92% in one year.
Market Cap
967.25M
Enterprise Value
634.78M
1-Year Change
112.92%
Global Rank
Country Rank
#2,257 United States
Category
ChartMarket Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $967.25M, an increase of 16.61%. That is a compound annual growth rate of 2.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 967.25M | 58.19% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| City Therapeutics | 1.03B |
| MoonLake Immunotherapeutics | 1.00B |
| Immatics | 984.17M |
| Rigel Pharmaceuticals | 958.46M |
| ORIC Pharmaceuticals | 957.75M |
| Odyssey Therapeutics | 936.33M |
| Latigo Biotherapeutics | 924.88M |
| Monte Rosa Therapeutics | 917.97M |